Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
1,595 USD | +0,31% | -0,31% | +12,77% |
15/03 | ATYR PHARMA, INC. : Opinion positive de RBC Capital Markets | ZM |
14/03 | Transcript : ATyr Pharma, Inc., Q4 2023 Earnings Call, Mar 14, 2024 |
Métier
Nombre d'employés: 58
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Innovative Medicines
100,0
%
| 10 | 100,0 % | 0 | 100,0 % | -96,60% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 10 | 100,0 % | 0 | 100,0 % | -96,60% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Sanjay Shukla
CEO | Chief Executive Officer | 52 | 30/03/16 |
Jill Broadfoot
DFI | Director of Finance/CFO | 63 | 30/07/18 |
Lisa Carey
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/15 |
Ashlee Dunston
IRC | Investor Relations Contact | - | 01/04/20 |
Peter Villiger
PRN | Corporate Officer/Principal | - | 01/05/16 |
Human Resources Officer | - | 24/12/21 | |
General Counsel | - | 06/10/21 | |
Leslie Nangle
PRN | Corporate Officer/Principal | - | - |
Nancy Krueger
LAW | General Counsel | 56 | 01/10/14 |
Andrew B. Cubitt
PRN | Corporate Officer/Principal | - | 01/09/11 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Paul Schimmel
FOU | Founder | 83 | 08/09/05 |
Tim Coughlin
CHM | Chairman | 57 | 10/04/17 |
John Clarke
BRD | Director/Board Member | 70 | 01/09/05 |
Sara Zaknoen
BRD | Director/Board Member | 65 | 25/05/21 |
Sanjay Shukla
CEO | Chief Executive Officer | 52 | 30/03/16 |
Jane Gross
BRD | Director/Board Member | 67 | 28/06/19 |
Svetlana Lucas
BRD | Director/Board Member | 52 | 28/06/19 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 67 940 841 | 66 158 839 ( 97,38 %) | 0 | 97,38 % |
Coordonnées société
aTyr Pharma, Inc.
10240 Sorrento Valley Road Suite 300
92121, San Diego
+858 731 8389
http://www.atyrpharma.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+12,77% | 108 M | |
+21,76% | 42,68 Md | |
-1,76% | 42,4 Md | |
+45,32% | 40,04 Md | |
-6,20% | 28,31 Md | |
+6,04% | 24,94 Md | |
-21,12% | 18,96 Md | |
+30,52% | 12,3 Md | |
-3,00% | 11,95 Md | |
-3,78% | 11,55 Md |
- Bourse
- Actions
- Action LIFE
- Société aTyr Pharma, Inc.